BlackRock Health Sciences Trust
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BlackRock Health Sciences Trust generated cash of $32,018,676, which is more than the previous year. Cash used in financing activities reached the amount of -$32,021,231 last year. Net change in cash is therefore -$2,584.
Cash Flow
| 2014 | 115.29M | 0 | -115.32M |
|---|---|---|---|
| 2015 | 1.27M | 44.08M | -39.78M |
| 2016 | 2.00M | 7.94M | -9.86M |
| 2017 | -1.16M | 8.77M | 961.51K |
| 2018 | 2.05M | 16.62M | -2.05M |
| 2019 | -14.10M | -32.01M | 14.22M |
| 2020 | -19.35M | -970.24K | 19.43M |
| 2021 | -21.55M | -35.54K | 21.34M |
| 2022 | -874.04K | -11.61M | 876.17K |
| 2023 | 32.01M | 0 | -32.02M |
BME Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.11K | 960 | 211.69K | 125.20K | 288 | 959 | 208.85K | 1.21K | 4.52K | 2.49K |
Operating activities | ||||||||||
Net income | 20.01M | -26.47M | 59.11M | 79.56M | 79.87M | 22.44M | 60.33M | -16.26M | 33.27M | 50.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.86K | 37.22K | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -17.81K | -146.88K | -7.21K | -39.38K | -55.18K | -96.21K | -3.17K | 110.42K | -17.89K | -422.73K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -21.71K | -3.62K | 37.71K | -267.87K | 412.69K | 20.52K | 51.53K | -26.19K | -6.91K | 0 |
Cash generated by operating activities | 32.01M | -874.04K | -21.55M | -19.35M | -14.10M | 2.05M | -1.16M | 2.00M | 1.27M | 115.29M |
Investing activities | ||||||||||
Purchases Of Investments | -241.73M | -244.08M | -280.66M | -133.08M | -214.06M | -126.85M | -114.57M | -156.76M | -210.32M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -11.61M | -35.54K | -970.24K | -32.01M | 16.62M | 8.77M | 7.94M | 44.08M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 3.02M | 33.61M | 50.32M | 45.08M | 37.49M | 19.54M | 20.97M | 13.18M | 9.43M | 0 |
Payments for dividends | -35.09M | -32.72M | -29.00M | -25.64M | -23.24M | -21.60M | -19.96M | -23.04M | -49.21M | -115.32M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 57.76K | 2.92K | 0 | 0 | 0 | -10.01K | 10.01K | 0 | 0 | 0 |
Cash used in financing activities | -32.02M | 876.17K | 21.34M | 19.43M | 14.22M | -2.05M | 961.51K | -9.86M | -39.78M | -115.32M |
Net Change In Cash | -2.58K | 2.15K | -210.73K | 86.49K | 124.91K | -671 | -207.89K | 207.64K | -3.31K | 2.02K |
Cash at end of period | 534 | 3.11K | 960 | 211.69K | 125.20K | 288 | 959 | 208.85K | 1.21K | 4.52K |